New eye drop enters testing for 'Silent' glaucoma
NCT ID NCT06030193
Summary
This study is testing a new eye drop called QLS-111 for people with normal tension glaucoma, a type where eye pressure is not high. It will compare the safety and ability to lower eye pressure of QLS-111 against a standard eye drop (timolol). The trial involves about 36 participants and is designed to see if the new drop is well-tolerated and effective.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Seoul National University Hospital
Seoul, 3080, South Korea
Conditions
Explore the condition pages connected to this study.